207 related articles for article (PubMed ID: 37802153)
1. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
[TBL] [Abstract][Full Text] [Related]
2. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
Emmerson JT; Do Carmo S; Liu Y; Shalhoub A; Liu A; Bonomo Q; Malcolm JC; Breuillaud L; Cuello AC
Neurobiol Dis; 2023 Aug; 184():106227. PubMed ID: 37454780
[TBL] [Abstract][Full Text] [Related]
3. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy.
Malcolm JC; Breuillaud L; Do Carmo S; Hall H; Welikovitch LA; Macdonald JA; Goedert M; Cuello AC
Neurobiol Dis; 2019 Jul; 127():323-338. PubMed ID: 30905766
[TBL] [Abstract][Full Text] [Related]
6. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
Komuro Y; Xu G; Bhaskar K; Lamb BT
Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
[TBL] [Abstract][Full Text] [Related]
7. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.
Koss DJ; Robinson L; Mietelska-Porowska A; Gasiorowska A; Sepčić K; Turk T; Jaspars M; Niewiadomska G; Scott RH; Platt B; Riedel G
Cell Mol Life Sci; 2015 Dec; 72(23):4613-32. PubMed ID: 26070304
[TBL] [Abstract][Full Text] [Related]
8. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.
Olešová D; Dobešová D; Majerová P; Brumarová R; Kvasnička A; Kouřil Š; Stevens E; Hanes J; Fialová Ľ; Michalicová A; Piešťanský J; Šinský J; Kaňovský P; Friedecký D; Kováč A
J Neuroinflammation; 2024 Mar; 21(1):78. PubMed ID: 38539208
[TBL] [Abstract][Full Text] [Related]
9. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology.
Koss DJ; Robinson L; Drever BD; Plucińska K; Stoppelkamp S; Veselcic P; Riedel G; Platt B
Neurobiol Dis; 2016 Jul; 91():105-23. PubMed ID: 26949217
[TBL] [Abstract][Full Text] [Related]
10. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
Dengler-Crish CM; Smith MA; Wilson GN
J Alzheimers Dis; 2017; 55(4):1605-1619. PubMed ID: 27814296
[TBL] [Abstract][Full Text] [Related]
11. Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.
Marquez A; Guernsey LS; Frizzi KE; Cundiff M; Constantino I; Muttalib N; Arenas F; Zhou X; Lim SH; Ferdousi M; Ponirakis G; Silverdale M; Kobylecki C; Jones M; Marshall A; Malik RA; Jolivalt CG
Neurobiol Dis; 2021 Apr; 151():105273. PubMed ID: 33482356
[TBL] [Abstract][Full Text] [Related]
12. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
[TBL] [Abstract][Full Text] [Related]
13. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.
Steuer EL; Kemper LJ; Hlynialuk CJW; Leinonen-Wright K; Montonye ML; Lapcinski IP; Forster CL; Ashe KH; Liu P
J Neurosci; 2022 Jun; 42(23):4737-4754. PubMed ID: 35508385
[TBL] [Abstract][Full Text] [Related]
14. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
[TBL] [Abstract][Full Text] [Related]
15. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L
Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372
[TBL] [Abstract][Full Text] [Related]
16. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
[TBL] [Abstract][Full Text] [Related]
17. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
[TBL] [Abstract][Full Text] [Related]
18. Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.
Chang JK; Leso A; Subaiea GM; Lahouel A; Masoud A; Mushtaq F; Deeb R; Eid A; Dash M; Bihaqi SW; Zawia NH
Curr Alzheimer Res; 2018; 15(7):655-663. PubMed ID: 29357795
[TBL] [Abstract][Full Text] [Related]
19. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
20. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
